Vaccine for the treatment of urinary tract infections containing aluminum phosphate
US4606919A · kind A · utility
11Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 30, 1985 |
| Grant date | Aug 19, 1986 |
| Priority date | — |
| Expiry date | Aug 30, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/885
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine for curative and prophylactic treatment of urinary tract infections in humans. The vaccine contains inactivated bacteria which originate from the cultures of 8 to 14 uropathogenic bacteria strains isolated from the urine of a person suffering from a urinary tract infection and aluminum phosphate in an amount of 1.5-10 mg of AlPO.sub.4 per ml of solution. Such bacteria are of the species E. coli, Klebsiella pneumoniae, Proteus mirabilis, Proteus morganii and Streptococcus faecolis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.